Delivery Order SPE2DB22D3501-SPE2DB24FVE77
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,263.17, is for the delivery of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a completion date of July 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,076.60 firm fixed-price contract is for the supply of "ZORYVE 0.3% FOAM 60GM", a pharmaceutical product, with a performance period through July 9, 2025. The contract is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,384.83, is for the supply of the pharmaceutical product ZORYVE 0.3% FOAM 60GM. The contract has a firm fixed price pricing type and a period of performance through February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, with a firm fixed price ceiling value of $1,392.55. The period of performance extends to May 16, 2025. This contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,120.26, is for the delivery of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 6, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567995030 - ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, with a ceiling value of $1,158.98. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,831.73 firm-fixed-price delivery order is for the supply of ZORYVE 0.3% FOAM 60GM, with a performance period ending on December 9, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for $1,846.66 to supply Zoryve 0.3% Foam in 60-gram quantities. The contract was competitively awarded without set-aside designation and carries a completion date of September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,161.02 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM, a topical pharmaceutical product. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division as a child delivery order under a...
- This is a firm fixed-price delivery order contract awarded by the Medical Supply Chain, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The total ceiling value of the contract is $3,699.34 and the ultimate completion date is May 16, 2025. The contract is not set-aside and was awarded on May 15, 2025. Amerisourcebergen Drug Corp is a for-profit...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVE77Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,166.99 contract is for the delivery of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, with a period of performance through April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver medications and healthcare materials to DLA Troop Support Medical in support of the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 4/8/24 |